Rankings
▼
Calendar
HRMY Q3 2019 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena
HRMY
Harmony Biosciences Holdings, Inc.
$2B
Q3 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$30M
Net Income
-$32M
EPS (Diluted)
$-0.74
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$23M
Free Cash Flow
-$23M
Stock-Based Comp.
$408,000
← FY 2019
All Quarters
Q4 2019 →
